Aspiriant LLC’s Vanguard Tax-Exempt Bond Index Fund VTEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216M Buy
4,272,813
+38,860
+0.9% +$1.95M 5.34% 6
2026
Q1
$211M Sell
4,233,953
-70,098
-2% -$3.54M 6.02% 5
2025
Q4
$216M Buy
4,304,051
+179,816
+4% +$9.05M 6.22% 5
2025
Q3
$207M Sell
4,124,235
-689,571
-14% -$33.9M 6.32% 6
2025
Q2
$236M Sell
4,813,806
-421,789
-8% -$20.6M 7.5% 5
2025
Q1
$260M Buy
5,235,595
+65,231
+1% +$3.26M 9.02% 5
2024
Q4
$259M Sell
5,170,364
-23,460
-0.5% -$1.19M 9.36% 4
2024
Q3
$266M Sell
5,193,824
-27,257
-0.5% -$1.38M 10.08% 3
2024
Q2
$262M Buy
5,221,081
+199,173
+4% +$9.97M 10.66% 1
2024
Q1
$254M Sell
5,021,908
-483,147
-9% -$24.5M 10.52% 2
2023
Q4
$281M Buy
5,505,055
+1,239,734
+29% +$60.8M 12.66% 1
2023
Q3
$205M Buy
4,265,321
+319,585
+8% +$15.8M 10.5% 2
2023
Q2
$198M Sell
3,945,736
-71,225
-2% -$3.58M 10.02% 2
2023
Q1
$203M Sell
4,016,961
-1,375,483
-26% -$69M 10.65% 2
2022
Q4
$267M Buy
5,392,444
+734,786
+16% +$35.9M 13.6% 1
2022
Q3
$224M Sell
4,657,658
-851,669
-15% -$42.6M 10.97% 2
2022
Q2
$275M Buy
5,509,327
+5,335,089
+3,062% +$267M 13.27% 2
2022
Q1
$8.98M Buy
174,238
+52,740
+43% +$2.81M 0.49% 28
2021
Q4
$6.67M Buy
121,498
+6,419
+6% +$352K 0.36% 38
2021
Q3
$6.3M Buy
115,079
+32,209
+39% +$1.78M 0.37% 32
2021
Q2
$4.58M Buy
82,870
+58,618
+242% +$3.23M 0.26% 43
2021
Q1
$1.33M Sell
24,252
-50,452
-68% -$2.77M 0.08% 87
2020
Q4
$4.12M Sell
74,704
-10,062
-12% -$549K 0.28% 37
2020
Q3
$4.62M Sell
84,766
-4,200
-5% -$229K 0.36% 34
2020
Q2
$4.82M Buy
88,966
+10,511
+13% +$560K 0.45% 31
2020
Q1
$4.15M Buy
+78,455
New +$4.2M 0.41% 34

Other funds holding VTEB

Aspiriant LLC's VTEB Position: Q2 2026 in Review

Aspiriant LLC increased its Vanguard Tax-Exempt Bond Index Fund (VTEB) stake by 0.92% in Q2 2026, buying an estimated $1.95M and bringing the position to 4,272,813 shares worth $216M. The position accounts for 5.34% of the portfolio, ranked #6.

Aspiriant LLC first reported a position in VTEB in Q1 2020 and has held it in 26 quarters since. The position peaked at $281M in Q4 2023. 1,401 funds tracked by Wall St. Rank hold VTEB as of Q2 2026.

  • Aspiriant LLC held 4,272,813 shares of Vanguard Tax-Exempt Bond Index Fund worth $216M as of Q2 2026.
  • Aspiriant LLC bought 38,860 Vanguard Tax-Exempt Bond Index Fund shares in Q2 2026, an estimated $1.95M.
  • Vanguard Tax-Exempt Bond Index Fund made up 5.34% of Aspiriant LLC's portfolio in Q2 2026, its #6 holding.
  • Aspiriant LLC first reported a position in Vanguard Tax-Exempt Bond Index Fund in Q1 2020 and has held it in 26 quarters since.
  • Aspiriant LLC's Vanguard Tax-Exempt Bond Index Fund position peaked at $281M in Q4 2023.
  • 1,401 funds tracked by Wall St. Rank held Vanguard Tax-Exempt Bond Index Fund as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.